Cargando…
Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis
L-carnitine (4-N-trimethylammonium-3-hydroxybutyric acid) is the physiologically active form of carnitine and is a natural compound that has been shown to exhibit antioxidant activity. L-carnitine is used as a supplementary treatment in patients with cirrhosis with hepatic encephalopathy, hyperammon...
Autores principales: | Sato, Shinya, Namisaki, Tadashi, Furukawa, Masanori, Saikawa, Soichiro, Kawaratani, Hideto, Kaji, Kosuke, Takaya, Hiroaki, Shimozato, Naotaka, Sawada, Yasuhiko, Kitagawa, Koh, Moriya, Kei, Akahane, Takemi, Mitoro, Akira, Hoki, Noriyuki, Ann, Tatsuichi, Yoshiji, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605124/ https://www.ncbi.nlm.nih.gov/pubmed/33149909 http://dx.doi.org/10.3892/br.2020.1372 |
Ejemplares similares
-
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
por: Sato, Shinya, et al.
Publicado: (2019) -
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
por: Moriya, Kei, et al.
Publicado: (2019) -
Late-Evening Snack with Branched-Chain Amino Acid-Enriched Nutrients Does Not Always Inhibit Overt Diabetes in Patients with Cirrhosis: A Pilot Study
por: Nakanishi, Keisuke, et al.
Publicado: (2019) -
Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020) -
Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy
por: Moriya, Kei, et al.
Publicado: (2021)